Michael Byrnes - May 13, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Chief Financial Officer
Signature
/s/ Michael Byrnes
Stock symbol
EFTR
Transactions as of
May 13, 2022
Transactions value $
$6,476
Form type
4
Date filed
5/17/2022, 08:46 PM
Previous filing
Jan 24, 2022
Next filing
Jun 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $6.48K +4.23K $1.53 4.23K May 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.